相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A phase 2 multicenter study of ublituximab, a novel glycoengineered anti-CD20 monoclonal antibody, in patients with relapsing forms of multiple sclerosis
Edward Fox et al.
MULTIPLE SCLEROSIS JOURNAL (2021)
The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody
Romana Hoeftberger et al.
ACTA NEUROPATHOLOGICA (2020)
Impact of treatment on cellular immunophenotype in MS A cross-sectional study
Maria Cellerino et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2020)
Progress in Multiple Sclerosis Research An Example of Bedside to Bench
Stephen L. Hauser
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Ofatumumab versus Teriflunomide in Multiple Sclerosis
Stephen L. Hauser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Imaging of meningeal inflammation should become part of the routine MRI protocol - Yes
Martina Absinta et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Neuromyelitis optica spectrum disorders: still evolving and broadening
Kazuo Fujihara
CURRENT OPINION IN NEUROLOGY (2019)
Characterization of leptomeningeal inflammation in rodent experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis
Suyog Pol et al.
EXPERIMENTAL NEUROLOGY (2019)
Membrane assembly of aquaporin-4 autoantibodies regulates classical complement activation in neuromyelitis optica
John Soltys et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder
S. J. Pittock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple Sclerosis
Xavier Montalban et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
CD4+count-dependent concentration-effect relationship of rituximab in rheumatoid arthritis
Amina Bensalem et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Early adaptive immune activation detected in monozygotic twins with prodromal multiple sclerosis
Eduardo Beltran et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Onset of clinical and MRI efficacy of ocrelizumab in relapsing multiple sclerosis
Frederik Barkhof et al.
NEUROLOGY (2019)
Intrathecal IgM production is a strong risk factor for early conversion to multiple sclerosis
Catherina Pfuhl et al.
NEUROLOGY (2019)
Anti-CD20 therapy depletes activated myelin-specific CD8+ T cells in multiple sclerosis
Joseph J. Sabatino et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Activated leukocyte cell adhesion molecule regulates B lymphocyte migration across central nervous system barriers
Laure Michel et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Circulating AQP4-specific auto-antibodies alone can induce neuromyelitis optica spectrum disorder in the rat
Sophie Hillebrand et al.
ACTA NEUROPATHOLOGICA (2019)
Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis
Roberta Magliozzi et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)
Myelin oligodendrocyte glycoprotein antibodies in neurological disease
Markus Reindl et al.
NATURE REVIEWS NEUROLOGY (2019)
Cladribine induces long lasting oligoclonal bands disappearance in relapsing multiple sclerosis patients: 10-year observational study
Konrad Rejdak et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
Comparison of Clinical Outcomes of Transverse Myelitis Among Adults With Myelin Oligodendrocyte Glycoprotein Antibody vs Aquaporin-4 Antibody Disease
Romina Mariano et al.
JAMA NETWORK OPEN (2019)
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations
Maciej Jurynczyk et al.
PRACTICAL NEUROLOGY (2019)
Inflammatory intrathecal profiles and cortical damage in multiple sclerosis
Roberta Magliozzi et al.
ANNALS OF NEUROLOGY (2018)
Pathogenicity of human antibodies against myelin oligodendrocyte glycoprotein
Melania Spadaro et al.
ANNALS OF NEUROLOGY (2018)
The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+T lymphocytes and B cells
Joana Machado-Santos et al.
BRAIN (2018)
ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis
X. Montalban et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
Human central nervous system astrocytes support survival and activation of B cells: implications for MS pathogenesis
Hanane Touil et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Cladribine treatment of multiple sclerosis is associated with depletion of memory B cells
Bryan Ceronie et al.
JOURNAL OF NEUROLOGY (2018)
CSF cytokine profile in MOG-IgG plus neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications
Kimihiko Kaneko et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)
Reassessing B cell contributions in multiple sclerosis
Rui Li et al.
NATURE IMMUNOLOGY (2018)
Different clinical response to interferon beta and glatiramer acetate related to the presence of oligoclonal IgM bands in CSF in multiple sclerosis patients
Bonaventura Casanova et al.
NEUROLOGICAL SCIENCES (2018)
Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis The MIRROR study
Amit Bar-Or et al.
NEUROLOGY (2018)
Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trial
Jerry S. Wolinsky et al.
ANNALS OF NEUROLOGY (2018)
Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis
Ivan Jelcic et al.
CELL (2018)
Functional characterization of reappearing B cells after anti-CD20 treatment of CNS autoimmune disease
Darius Haeusler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Restoration of regulatory B cell deficiency following alemtuzumab therapy in patients with relapsing multiple sclerosis
Yeseul Kim et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Intrathecal treatment trial of rituximab in progressive MS An open-label phase 1b study
Joakim Bergman et al.
NEUROLOGY (2018)
B cells from patients with multiple sclerosis. induce cell death via apoptosis in neurons in vitro
Robert P. Lisak et al.
JOURNAL OF NEUROIMMUNOLOGY (2017)
Human antibodies against the myelin oligodendrocyte glycoprotein can cause complement-dependent demyelination
Patrick Peschl et al.
JOURNAL OF NEUROINFLAMMATION (2017)
Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study
Gabriele Farina et al.
JOURNAL OF NEUROINFLAMMATION (2017)
Monitoring CD27+memory B-cells in neuromyelitis optica spectrum disorders patients treated with rituximab: Results from a bicentric study
M. Cohen et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2017)
Soluble TACI and soluble BCMA as biomarkers in primary central nervous system lymphoma
Franziska S. Thaler et al.
NEURO-ONCOLOGY (2017)
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
S. L. Hauser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
X. Montalban et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Autoantibody-induced internalization of CNS AQP4 water channel and EAAT2 glutamate transporter requires astrocytic Fc receptor
Shannon R. Hinson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Memory B Cells are Major Targets for Effective Immunotherapy in Relapsing Multiple Sclerosis
David Baker et al.
EBIOMEDICINE (2017)
Myelin-specific multiple sclerosis antibodies cause complement-dependent oligodendrocyte loss and demyelination
Yiting Liu et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
Clinical presentation and prognosis in MOG-antibody disease: a UK study
Maciej Jurynczyk et al.
BRAIN (2017)
Rituximab in paediatric onset multiple sclerosis: a case series
Jonatan Salzer et al.
JOURNAL OF NEUROLOGY (2016)
Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial
Fred Lublin et al.
LANCET (2016)
The search for the target antigens of multiple sclerosis, part 2: CD8+T cells, B cells, and antibodies in the focus of reverse-translational research
Reinhard Hohlfeld et al.
LANCET NEUROLOGY (2016)
The search for the target antigens of multiple sclerosis, part 1: autoreactive CD4+T lymphocytes as pathogenic effectors and therapeutic targets
Reinhard Hohlfeld et al.
LANCET NEUROLOGY (2016)
Rituximab in multiple sclerosis A retrospective observational study on safety and efficacy
Jonatan Salzer et al.
NEUROLOGY (2016)
Distinct oligoclonal band antibodies in multiple sclerosis recognize ubiquitous self-proteins
Simone M. Braendle et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Integration of Th17-and Lymphotoxin-Derived Signals Initiates Meningeal-Resident Stromal Cell Remodeling to Propagate Neuroinflammation
Natalia B. Pikor et al.
IMMUNITY (2015)
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study
J. Kuhle et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
Dean M. Wingerchuk et al.
NEUROLOGY (2015)
Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis
Martina Absinta et al.
NEUROLOGY (2015)
Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy
Rui Li et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study
J. Kuhle et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
MOG cell-based assay detects non-MS patients with inflammatory neurologic disease
Patrick Waters et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
Targets of the humoral autoimmune response in multiple sclerosis
Judith Fraussen et al.
AUTOIMMUNITY REVIEWS (2014)
Defining the clinical course of multiple sclerosis The 2013 revisions
Fred D. Lublin et al.
NEUROLOGY (2014)
Rituximab Use in Pediatric Central Demyelinating Disease
Shannon J. Beres et al.
PEDIATRIC NEUROLOGY (2014)
Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis
Arumugam Palanichamy et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes
Joel N. H. Stern et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Involvement of antibody-dependent cell-mediated cytotoxicity in inflammatory demyelination in a mouse model of neuromyelitis optica
Julien Ratelade et al.
ACTA NEUROPATHOLOGICA (2013)
Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis optica
Tatsuro Misu et al.
ACTA NEUROPATHOLOGICA (2013)
Disease-modifying treatments for progressive multiple sclerosis
Giancarlo Comi
MULTIPLE SCLEROSIS JOURNAL (2013)
B cell exchange across the blood-brain barrier in multiple sclerosis
H. -Christian von Buedingen et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitro
Robert P. Lisak et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
Rituximab Therapy Leads to Reduced Imprints of Receptor Revision in Immunoglobulin κ and λ Light Chains
Arumugam Palanichaimy et al.
JOURNAL OF RHEUMATOLOGY (2012)
Interferon Beta-1b for the Treatment of Primary Progressive Multiple Sclerosis Five-Year Clinical Trial Follow-up
Carmen Tur et al.
ARCHIVES OF NEUROLOGY (2011)
Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders
Simone Mader et al.
JOURNAL OF NEUROINFLAMMATION (2011)
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
Ludwig Kappos et al.
LANCET (2011)
Abnormal B-Cell Cytokine Responses A Trigger of T-Cell Mediated Disease in MS?
Amit Bar-Or et al.
ANNALS OF NEUROLOGY (2010)
Rituximab in Patients with Primary Progressive Multiple Sclerosis Results of a Randomized Double-Blind Placebo-Controlled Multicenter Trial
Kathleen Hawker et al.
ANNALS OF NEUROLOGY (2009)
A single-center, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis
X. Montalban et al.
MULTIPLE SCLEROSIS JOURNAL (2009)
Helminth infections associated with multiple sclerosis induce regulatory B cells
Jorge Correale et al.
ANNALS OF NEUROLOGY (2008)
Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis
Birgit Obermeier et al.
NATURE MEDICINE (2008)
B-cell depletion with Rituximab in relapsing-remitting multiple sclerosis
Stephen L. Hauser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology
Roberta Magliozzi et al.
BRAIN (2007)
Lack of association between antimyelin antibodies and progression to multiple sclerosis
Jens Kuhle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double-blind, placebo-controlled trial
Jerry S. Wolinsky et al.
ANNALS OF NEUROLOGY (2007)
Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients
Anne H. Cross et al.
JOURNAL OF NEUROIMMUNOLOGY (2006)
Regeneration of B cell subsets after transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis
Petra Roll et al.
ARTHRITIS AND RHEUMATISM (2006)
Lymphoid neogenesis in chronic inflammatory diseases
F Aloisi et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis
MJ Leandro et al.
ARTHRITIS AND RHEUMATISM (2006)
B lineage cells in the inflammatory central nervous system environment: Migration, maintenance, local antibody production, and therapeutic modulation
E Meinl et al.
ANNALS OF NEUROLOGY (2006)
BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma
M Krumbholz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis
A Bar-Or et al.
BRAIN (2003)
Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event
T Berger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Rituximab therapy and autoimmune disorders - Prospects for anti-B cell therapy
GJ Silverman et al.
ARTHRITIS AND RHEUMATISM (2003)
Determinants of human B cell migration across brain endothelial cells
A Alter et al.
JOURNAL OF IMMUNOLOGY (2003)
Intrathecal IgM synthesis is a prognostic factor in multiple sclerosis
LM Villar et al.
ANNALS OF NEUROLOGY (2003)
分享论文
